Is LUV Stock a Buy, Sell or Hold?
Southwest Airlines (NYSE:LUV) is one of America’s major air transportation…
Sell
32
LULU Quote, Financials, Valuation and Earnings
Last price:
$255.65
Seasonality move
:
6.62%
Day range:
$276.51 - $287.95
52-week range:
$226.01 - $423.32
Dividend yield:
0%
P/E ratio:
19.23x
P/S ratio:
3.31x
P/B ratio:
7.89x
Volume:
2.3M
Avg. volume:
2.3M
1-year change:
-25.21%
Market cap:
$34.1B
Revenue:
$10.6B
EPS (TTM):
$14.70
Analysts' Opinion
-
Consensus RatingLululemon Athletica has received a consensus rating of Buy. The company's average rating is a Buy based on 15 Buy ratings, 14 Hold ratings, and 2 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $360.92, Lululemon Athletica has an estimated upside of 27.65% from its current price of $282.75.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $194.00 representing 31.39% downside risk from its current price of $282.75.
Fair Value
-
According to the consensus of 31 analysts, Lululemon Athletica has 27.65% upside to fair value with a price target of $360.92 per share.
LULU vs. S&P 500
-
Over the past 5 trading days, Lululemon Athletica has underperformed the S&P 500 by -17.62% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Lululemon Athletica does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Lululemon Athletica has grown year-over-year revenues for 19 quarters straight. In the most recent quarter Lululemon Athletica reported revenues of $3.6B.
Earnings Growth
-
Lululemon Athletica has grown year-over-year earnings for 5 quarters straight. In the most recent quarter Lululemon Athletica reported earnings per share of $6.14.
Enterprise value:
32.1B
EV / Invested capital:
7.43x
Price / LTM sales:
3.31x
EV / EBIT:
12.82x
EV / Revenue:
3.03x
PEG ratio (5yr expected):
0.94x
EV / Free cash flow:
20.29x
Price / Operating cash flow:
22.13x
Enterprise value / EBITDA:
10.88x
Gross Profit (TTM):
$6.3B
Return On Assets:
25.67%
Net Income Margin (TTM):
17.14%
Return On Equity:
43.64%
Return On Invested Capital:
43.64%
Operating Margin:
28.86%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $8.1B | $9.6B | $10.6B | $3.2B | $3.6B | |
| Gross Profit | $4.5B | $5.6B | $6.3B | $1.9B | $2.2B | |
| Operating Income | $1.7B | $2.2B | $2.5B | $913.9M | $1B | |
| EBITDA | $2B | $2.6B | $3B | $1B | $1.2B | |
| Diluted EPS | $6.68 | $12.20 | $14.70 | $5.28 | $6.14 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $2.1B | $2.6B | $3.2B | $4.1B | $4B | |
| Total Assets | $4.2B | $4.9B | $5.6B | $7.1B | $7.6B | |
| Current Liabilities | $883.2M | $1.4B | $1.5B | $1.6B | $1.8B | |
| Total Liabilities | $1.6B | $2.2B | $2.5B | $2.9B | $3.3B | |
| Total Equity | $2.6B | $2.7B | $3.1B | $4.2B | $4.3B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $966.5M | $2.3B | $2.3B | $1.4B | $1.4B | |
| Cash From Investing | -$569.9M | -$654.1M | -$798.2M | -$208.8M | -$223M | |
| Cash From Financing | -$467.5M | -$548.8M | -$1.7B | -$38.2M | -$324M | |
| Free Cash Flow | $327.8M | $1.6B | $1.6B | $1.2B | $1.2B | |
LULU
Sector
Market Cap
$34.1B
$417.1M
Price % of 52-Week High
66.79%
69.3%
Dividend Yield
0%
0%
Shareholder Yield
3.25%
3.88%
1-Year Price Total Return
-25.21%
-17.24%
Beta (5-Year)
1.312
0.834
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$311.27
200-day SMA
Sell
Level
$317.45
Bollinger Bands (100)
Sell
Level
321.92 - 395.26
Chaikin Money Flow
Buy
Level
94.5M
20-day SMA
Sell
Level
$320.77
Relative Strength Index (RSI14)
Sell
Level
28.24
ADX Line
Sell
Level
32.04
Williams %R
Buy
Level
-91.3321
50-day SMA
Sell
Level
$360.17
MACD (12, 26)
Sell
Level
-18.24
25-day Aroon Oscillator
Sell
Level
-96
On Balance Volume
Neutral
Level
281.2M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (12.8041)
Buy
CA Score
(Annual)
Level (2.0161)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.2923)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 760 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East. The company was founded in 1998 and is based in Vancouver, Canada.
Stock Forecast FAQ
In the current month, LULU has received 15 Buy ratings 14 Hold ratings, and 2 Sell ratings. The LULU average analyst price target in the past 3 months is $360.92.
-
Where Will Lululemon Athletica Stock Be In 1 Year?
According to analysts, the consensus estimate is that Lululemon Athletica share price will rise to $360.92 per share over the next 12 months.
-
What Do Analysts Say About Lululemon Athletica?
Analysts are divided on their view about Lululemon Athletica share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lululemon Athletica is a Sell and believe this share price will drop from its current level to $194.00.
-
What Is Lululemon Athletica's Price Target?
The price target for Lululemon Athletica over the next 1-year time period is forecast to be $360.92 according to 31 Wall Street analysts, 15 of them rate the stock a Buy, 2 rate the stock a Sell, and 14 analysts rate the stock a Hold.
-
Is LULU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Lululemon Athletica is a Buy. 15 of 31 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of LULU?
You can purchase shares of Lululemon Athletica via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lululemon Athletica shares.
-
What Is The Lululemon Athletica Share Price Today?
Lululemon Athletica was last trading at $255.65 per share. This represents the most recent stock quote for Lululemon Athletica. Yesterday, Lululemon Athletica closed at $282.75 per share.
-
How To Buy Lululemon Athletica Stock Online?
In order to purchase Lululemon Athletica stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Should I Buy Alcoa Stock?
Alcoa (AA) finds itself in an interesting position in early…
Where Will Nu Holdings Stock Be in 2030?
Despite fast growth, high profitability and an extraordinary runway ahead,…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
43
MNPR alert for Apr 3
Monopar Therapeutics [MNPR] is down 10.04% over the past day.
Buy
75
BKTI alert for Apr 3
BK Technologies [BKTI] is down 7.68% over the past day.
Sell
34
SWTX alert for Apr 3
SpringWorks Therapeutics [SWTX] is down 7.29% over the past day.
